Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Mar 14;12(1):25.
doi: 10.1186/s13000-017-0614-7.

Implication of overexpression of dishevelled-associated activator of morphogenesis 1 (Daam-1) for the pathogenesis of human Idiopathic Pulmonary Arterial Hypertension (IPAH)

Affiliations

Implication of overexpression of dishevelled-associated activator of morphogenesis 1 (Daam-1) for the pathogenesis of human Idiopathic Pulmonary Arterial Hypertension (IPAH)

Shun Yanai et al. Diagn Pathol. .

Abstract

Background: Idiopathic pulmonary arterial hypertension (IPAH) is a rare, fatal disease of unknown pathogenesis. Evidence from our recent study suggests that IPAH pathogenesis is related to upregulation of the Wnt/planar cell polarity (Wnt/PCP) pathway. We used microscopic observation and immunohistochemical techniques to identify expression patterns of cascading proteins-namely Wnt-11, dishevelled-2 (Dvl-2), and dishevelled-associated activator of morphogenesis 1 (Daam-1)-in pulmonary arteries.

Methods: We analyzed sections of formalin-fixed and paraffin-embedded autopsied lung tissues obtained from 9 IPAH cases, 7 associated pulmonary arterial hypertension cases, and 16 age-matched controls without pulmonary arterial abnormalities. Results of microscopic observation were analyzed in relation to the cellular components and size of pulmonary arteries.

Results: Varying rates of positive reactivity to Dvl-2 and Daam-1 were confirmed in all cellular components of pulmonary arteries, namely, endothelial cells, myofibroblasts, and medial smooth muscle cells. In contrast, none of these components was reactive to Wnt-11. No specific expression patterns were observed for endothelial cells or myofibroblasts under any experimental conditions. However, marked expression of Dvl-2 and Daam-1 was confirmed in smooth muscle cells. In addition, Dvl-2 was depleted while Daam-1 expression was elevated in IPAH, in contrast with specimens from associated pulmonary arterial hypertension cases and controls.

Conclusions: High Daam-1 expression may upregulate the Wnt/PCP pathway and cause IPAH.

Keywords: Daam-1; IPAH; Overexpression; Smooth muscle cells; Wnt/PCP pathway.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Photomicrographs of anti–Wnt-11 antibody immunostaining. a Control: positive reactivity is confirmed in parietal cells of gastric fundic glands. b IPAH, PA: positive reactivity is not confirmed in endothelial cells, myofibroblasts, or SMC. c APAH, PA: positive reactivity is not confirmed in endothelial cells, myofibroblasts, or SMC. d Age-matched control, PA: positive reactivity is not confirmed in endothelial cells, myofibroblasts, or SMC
Fig. 2
Fig. 2
Photomicrographs of anti–Dvl-2 antibody immunostaining. a Built-in control: positive reactivity is confirmed in bronchial epithelial cells. b IPAH, PA: positive reactivity is confirmed in endothelial cells and SMC. c APAH, PA: positive reactivity is confirmed in endothelial cells and SMC. d Age-matched control, PA: positive reactivity is confirmed in endothelial cells and SMC
Fig. 3
Fig. 3
Photomicrographs of anti–Daam-1 antibody immunostaining. a Built-in control: positive reactivity is confirmed in bronchial epithelial cells. b IPAH, PA: positive reactivity is confirmed in endothelial cells, and SMC. c APAH, PA: positive reactivity is observed in endothelial cells and SMC. d Age-matched control, PA: positive reactivity is observed in endothelial cells and SMC
Fig. 4
Fig. 4
Positive expression rates of Dvl-2 and Daam-1 in pulmonary arteries from autopsy cases. a, Small arteries. b, Medium-sized arteries. * P < 0.05
Fig. 5
Fig. 5
Ratio of positive expression rates (Daam-1/Dvl-2)

Similar articles

Cited by

References

    1. Fishman AP. Primary pulmonary arterial hypertension: a lookback. J Am Coll Cardiol. 2004;43:2S–4S. doi: 10.1016/j.jacc.2004.03.019. - DOI - PubMed
    1. Lai Y-C, Potoka KC, Champion HC, Mora AL, Gladwin MT. Pulmonary arterial hypertension: the clinical syndrome. Circ Res. 2014;115:115–130. doi: 10.1161/CIRCRESAHA.115.301146. - DOI - PMC - PubMed
    1. Saji T. Update on pediatric pulmonary arterial hypertension: differences and similarities to adult disease. Circ J. 2013;77:2639–2650. doi: 10.1253/circj.CJ-13-1180. - DOI - PubMed
    1. Simonneau G, Gatzoulis MA, Adatia I, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2013;62:D34–D41. doi: 10.1016/j.jacc.2013.10.029. - DOI - PubMed
    1. Ma L, Chung WK. The genetic basis of pulmonary arterial hypertension. Hum Genet. 2014;133:471–479. doi: 10.1007/s00439-014-1419-3. - DOI - PubMed

Substances

LinkOut - more resources